4//SEC Filing
ALLERGAN INC 4
Accession 0000850693-04-000075
CIK 0000850693operating
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 7:07 PM ET
Size
8.4 KB
Accession
0000850693-04-000075
Insider Transaction Report
Form 4
ALLERGAN INC(AGN)
ROSSO LOUIS T
Director
Transactions
- Award
Phantom Stock Units
2004-09-28$74.66/sh+26.79$2,000→ 21,669.02 totalExercise: $0.00→ Common Stock (0 underlying) - Award
Phantom Stock Units
2004-09-19$75.75/sh+25.68$1,945→ 21,642.23 totalExercise: $0.00→ Common Stock (0 underlying)
Footnotes (4)
- [F1]Converts to common stock on a 1-for-1 basis.
- [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly dividend, exempt transaction under Rule 16a-11.
- [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
- [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
Documents
Issuer
ALLERGAN INC
CIK 0000850693
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850693
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 7:07 PM ET
- Size
- 8.4 KB